WallStSmart

Palantir Technologies Inc. (PLTR)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Palantir Technologies Inc. generates 2130% more annual revenue ($6.16B vs $276.03M). PLTR leads profitability with a 49.0% profit margin vs -15.8%. PLTR earns a higher WallStSmart Score of 75/100 (B).

PLTR

Strong Buy

75

out of 100

Grade: B

Growth: 10.0Profit: 10.0Value: 2.7Quality: 9.0
Piotroski: 5/9Altman Z: 4.71

ZEPP

Hold

36

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 6/9Altman Z: 0.63
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PLTRSignificantly Overvalued (-83.0%)

Margin of Safety

-83.0%

Fair Value

$91.40

Current Price

$167.23

$75.83 premium

UndervaluedFair: $91.40Overvalued

Intrinsic value data unavailable for ZEPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PLTR6 strengths · Avg: 10.0/10
Market CapQuality
$401.86B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
30.9%10/10

Every $100 of equity generates 31 in profit

Profit MarginProfitability
49.0%10/10

Keeps 49 of every $100 in revenue as profit

Operating MarginProfitability
47.1%10/10

Strong operational efficiency at 47.1%

Revenue GrowthGrowth
92.8%10/10

Revenue surging 92.8% year-over-year

EPS GrowthGrowth
215.4%10/10

Earnings expanding 215.4% YoY

ZEPP1 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Areas to Watch

PLTR3 concerns · Avg: 2.7/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

P/E RatioValuation
141.7x2/10

Premium valuation, high expectations priced in

Price/BookValuation
41.1x2/10

Trading at 41.1x book value

ZEPP4 concerns · Avg: 2.5/10
Market CapQuality
$72.15M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.333/10

Elevated debt levels

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : PLTR

The strongest argument for PLTR centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 49.0% and operating margin at 47.1%. Revenue growth of 92.8% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book.

Bear Case : PLTR

The primary concerns for PLTR are PEG Ratio, P/E Ratio, Price/Book. A P/E of 141.7x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Debt/Equity, Return on Equity.

Key Dynamics to Monitor

PLTR profiles as a growth stock while ZEPP is a turnaround play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.89 — expect wider price swings.

PLTR is growing revenue faster at 92.8% — sustainability is the question.

PLTR generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

PLTR scores higher overall (75/100 vs 36/100), backed by strong 49.0% margins and 92.8% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Palantir Technologies Inc.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Palantir Technologies Inc. creates and implements software platforms for the intelligence community in the United States to assist in counterterrorism investigations and operations. The company is headquartered in Denver, Colorado.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?